Aclaris Therapeutics to Attend Upcoming Investor Conferences
Get Alerts ACRS Hot Sheet
Join SI Premium – FREE
MALVERN, Pa., Aug. 17, 2017 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a dermatologist-led biopharmaceutical company focused on identifying, developing and commercializing innovative and differentiated therapies to address significant unmet needs in medical and aesthetic dermatology, today announced that members of its management team will present and host investor meetings at the following upcoming investor events:
- Management will host investor meetings during Citi’s 12th Annual Biotech Conference in Boston, MA on Wednesday, September 6, 2017.
- Dr. Neal Walker, President and Chief Executive Officer, will present at the Morgan Stanley 15th Annual Global Healthcare Conference in New York, NY on Tuesday, September 12, 2017 at 5:15 PM EDT.
- Dr. Walker will also present at the Cantor Fitzgerald Global Healthcare Conference in New York, NY on Tuesday, September 26, 2017 at 9:10 AM EDT.
A live webcast of the Morgan Stanley 15th Annual Global Healthcare Conference and the Cantor Fitzgerald Global Healthcare Conference presentations may be accessed through the Company's web site, www.aclaristx.com, on the 'Events and Presentations' section. An archived version of the presentation will be available for 30 days.
About Aclaris Therapeutics, Inc.Aclaris Therapeutics, Inc. is a dermatologist-led biopharmaceutical company focused on identifying, developing and commercializing innovative and differentiated therapies to address significant unmet needs in medical and aesthetic dermatology. Aclaris is focused on large, underserved market segments with no FDA-approved medications or where treatment gaps exist. Aclaris is based in Malvern, Pennsylvania and more information can be found by visiting the Aclaris website at www.aclaristx.com.
Contact: Aclaris Contact Michael Tung, M.D. Vice President / Investor Relations 484-329-2140 [email protected] Media Contact Mariann Caprino TogoRun 917-242-1087 [email protected]Source: Aclaris Therapeutics, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SpaceX sets IPO price at $135 ahead of roadshow in break with Wall Street norms
- Niloufar Banisaied and Her Longstanding Presence in Hospitality
- Suncadia Debuts Suncadia Social with a Three-Day Grand Opening Celebration, June 19-21
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Cantor Fitzgerald, Citi, Morgan Stanley, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share